Technion, Telehealth & Telemedicine

Technion professor in the Rappaport Faculty of Medicine and Attending Physician in Infectious Diseases at the Rambam Health Care Campus Dr. Yael Shachor-Meyouhas shares her insights on the COVID-19 pandemic. This includes the unique Technion advantage in applying telehealth and telemedicine, as well as the research promise within the evidence that young people are much less affected by Corona.

Why do young people respond differently?

On the frontline of treating past, present and future carriers of the Covid-19 in Israel, Prof. Yael Shachor-Meyouhas is an Attending Physician in the Infectious Diseases Unit at Rambam Health Care Campus and the Deputy Director of Ruth Rappaport Children’s Hospital. According to her, young people may hold the key to this, and many other future viruses. 

“We didn’t see any mortality in Italy so far in patients under the age of 29,” she says. “It’s amazing because it’s different from many other viruses. After we perform those clinical studies, we can go back to the laboratories we have at the Technion – and we have many – and we can learn about this virus and many other viruses, and then we can go back to the clinical field and see if we can find a drug or even a vaccine for this virus and many other viruses that can cause severe illness.”

Dr. Shachor-Meyouhas is a graduate of the Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology and completed her internship and residencies in pediatrics (2006) and infectious diseases (2009) at Rambam Health Care Campus. 

Here at Rambam, we treat those patients in isolation using new technology – telehealth and telemedicine – and I think the Technion is a great platform for using those technologies and to help us develop those technologies to help us contain the Coronavirus outbreak,” says Dr. Shachor-Meyouhas.

Her main research interests are Infectious diseases among immunocompromised patients, fungal infections, viral infections, and hospital-acquired infections. She is a member of the European Society of Pediatric Infectious Diseases and a member of the organizing committee for the Israeli Pediatric Infectious Disease Society. She has authored more than 30 publications and a chapter about pediatric legionellosis in Decision Support Medicine.